Maciej Boni and colleagues discuss a new model exploring how a switch in antimalarial drug use to artemisinin-based combination therapies will affect malaria prevalence and incidence in endemic regions.
Chanaki Amaratunga, Mehul Dhorda, R. van der Pluijm, Joel Tärning, Ricardo Águas, Maciej F. Boni, Phaik Yeong Cheah, Paulina Tindana, Freek de Haan, Wouter Boon, Ellen H.M. Moors, Katherine Plewes, Rupam Tripura, Nick Day, Sir Nicholas White, Arjen M. Dondorp
Discussion(0)
No comments yet. Be the first to comment.